Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-051559
Filing Date
2022-09-29
Accepted
2022-09-29 18:05:19
Documents
1
Period of Report
2022-09-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10303
  Complete submission text file 0001209191-22-051559.txt   11747
Mailing Address C/O ARQULE, INC. 1 WALL STREET, 6TH FLOOR BURLINGTON MA 01803
Business Address
LOBERG MICHAEL D (Reporting) CIK: 0001233414 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39045 | Film No.: 221281713

Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Issuer) CIK: 0001496323 (see all company filings)

EIN.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations